Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
International Journal of Urology : Official Journal of the Japanese Urological Association|October 28, 2022
Diagnostic and prognostic significance of tartrate-resistant acid phosphatase type 5b in newly diagnosed prostate cancer with bone metastasis: A real-world multi-institutional studyGaku Yamamichi, Taigo Kato, Satoru Yumiba, et al.
Cancer Science|October 7, 2017
Expression level of CXCL7 in peripheral blood cells is a potential biomarker for the diagnosis of renal cell carcinomaToshiro Kinouchi, Motohide Uemura, Cong Wang, et al.
International Journal of Molecular Sciences|August 6, 2020
Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial CarcinomaEisuke Tomiyama, Kazutoshi Fujita, Maria Del Carmen Rodriguez Pena, et al.
The Prostate|August 29, 2017
Peripheral blood monocyte count reflecting tumor-infiltrating macrophages is a predictive factor of adverse pathology in radical prostatectomy specimensTakuji Hayashi, Kazutoshi Fujita, Satoshi Nojima, et al.
BMC Urology|July 9, 2025
Preoperative CRP is a predictive factor for prolonged hospital stay after radical cystectomy for bladder cancerTakuji Hayashi, Atsunari Kawashima, Takeshi Ujike, et al.
Anticancer Research|September 4, 2020
A Potential Mechanism of Anticancer Immune Response Coincident With Immune-related Adverse Events in Patients With Renal Cell CarcinomaTaigo Kato, Eisuke Tomiyama, Yoko Koh, et al.
Biomarker Research|November 26, 2024
GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironmentGaku Yamamichi, Taigo Kato, Noriaki Arakawa, et al.
Cancer Science|March 15, 2021
Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkersEisuke Tomiyama, Kyosuke Matsuzaki, Kazutoshi Fujita, et al.
Cancer Science|March 20, 2019
Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinomaYujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
Japanese Journal of Clinical Oncology|February 2, 2024
Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC studyAkira Nagahara, Motohide Uemura, Mototaka Sato, et al.
Pageof 9